🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Magnificent panel discussion on IO. Do we give more post op IO after neoadjuvant in a strained healthcare system? ETOP IBCSG Partners Foundation ADOPT trial will answer this, but “cure may come at a cost” BTOG #BTOG25

Registration and application now open - ETOP Annual Meeting 2025 and 14th ETOP Residential Workshop - mailchi.mp/bf8914e6f575/e…

The history of IBCSG published in Oncopedia - European History of Oncology - ibcsg.org/en/all-news-an…

Ross Soo presenting the ETOP AMAZE-lung trial at #ELCC2025 . ESMO - Eur. Oncology

Sabine Schmid presenting the TiP-poster for the ETOP 25-23 ADOPT-lung trial at #ELCC2025. ⁦ESMO - Eur. Oncology⁩ ⁦NHMRC CTC⁩ ⁦Thoracic Oncology Group of Australasia⁩ ⁦SAKK⁩

New publication: Genomic Characterization and Prognostic Significance of Human Epidermal Growth Factor Receptor 2–Low, Hormone Receptor–Positive, Early Breast Cancers From the BIG 1-98 and SOFT Clinical Trials ascopubs.org/doi/10.1200/PO…

ETOP Live Webinar: Highlights of AACR and ASCO 2025 - mailchi.mp/d90036dc8d43/w…

Register now for the next ETOP Live Webinar: Highlights of AACR and ASCO 2025: register.gotowebinar.com/register/76848…

Out now in Lung Cancer Journal: Multimodality treatment in synchronous oligometastatic NSCLC: Analysis of the ETOP CHESS trial: authors.elsevier.com/a/1l0RScYZOisEb Cohort 2 with Tremelimumab in addition to Durvalumab is still recruiting: etop.ibcsg.org/projects/clini… Grupo Español de Cáncer de Pulmón; SAKK

With the North Estonia Medical Centre, the first European site has been activated for our ETOP 25-23 ADOPT-lung trial: etop.ibcsg.org/projects/clini…; Thoracic Oncology Group of Australasia, NHMRC CTC, SAKK

ETOP Slide Deck of AACR Annual Meeting 2025 - mailchi.mp/ee2fc029939a/w…

We are happy to announce that the ETOP Slide deck of the AACR Annual Meeting 2025 is now available online. etop.ibcsg.org/research-and-n…

Hormonal Factors Predictive of Fertility in Patients with Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy. Don't miss the latest results of the IBCSG 48-14/BIG 8-13 POSITIVE trial on Wed, May 14 at 2025 - ESMO Breast. Proffered Papers 1 - 17.14 PM CEST.

Lower AMH at 3 mths was associated w/ lower pregnancy rate. Higher FSH at mth 3 was modestly associated w/ lower spontaneous pregnancy. Conclusion of the #POSITIVETrial is presented by Fedro Peccatori MD, PhD at #ESMOBreast25 ETOP IBCSG Partners Foundation Alliance Foundation Trials

#ESMOBreast25 #328P BIG survey results from 237 physicians, 38 countries: 60% believe HER2+ MBC pts can be cured; 44% agree maintenance anti-HER2 can be stopped; but <25% of HER2+ MBC long-term survivors w/ no evidence of disease discontinued HER2 target therapy.

Delayed post! This time last week, the ETOP IBCSG Partners Foundation lung group had their annual translational meeting. A dynamic day, discussing - Biomarker platform studies (Lungscope, Lungscape, Mesoscope, Smallscope) - Translational work on etop trials & a privilege to co-lead #Lungscape!

#ESMObreast25 has come to a close with major insights from BIG studies. From long-term survival data to fertility and patient-reported outcomes, here are key takeaways from the event. #Aphinitytrial #Optimatrial #Positivetrial #ALTTOtrial #Pallastrial #ALPHABETtrial #BCSM

New publication out on the IBCSG 35-07 SOLE trial: ejcancer.com/article/S0959-…

New publication out on the IBCSG 61-20/ BCT 1902 Neo-N trial, sponsored by Breast Cancer Trials : thelancet.com/journals/lanon…

Read here our ETOP IBCSG Partners Foundation Annual Report 2024, which highlights the Foundation's many activities and achievements. This year has been defined by remarkable progress as well as persistent challenges in the global fight against cancer. etop.ibcsg.org/about-us/etop-…